These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 14519655

  • 1. Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET.
    Jiang WG, Grimshaw D, Martin TA, Davies G, Parr C, Watkins G, Lane J, Abounader R, Laterra J, Mansel RE.
    Clin Cancer Res; 2003 Sep 15; 9(11):4274-81. PubMed ID: 14519655
    [Abstract] [Full Text] [Related]

  • 2. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
    Martin TA, Parr C, Davies G, Watkins G, Lane J, Matsumoto K, Nakamura T, Mansel RE, Jiang WG.
    Carcinogenesis; 2003 Aug 15; 24(8):1317-23. PubMed ID: 12807719
    [Abstract] [Full Text] [Related]

  • 3. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
    Davies G, Mason MD, Martin TA, Parr C, Watkins G, Lane J, Matsumoto K, Nakamura T, Jiang WG.
    Int J Cancer; 2003 Sep 01; 106(3):348-54. PubMed ID: 12845672
    [Abstract] [Full Text] [Related]

  • 4. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J.
    FASEB J; 2002 Jan 01; 16(1):108-10. PubMed ID: 11729097
    [Abstract] [Full Text] [Related]

  • 5. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
    Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P, Laterra J.
    J Natl Cancer Inst; 1999 Sep 15; 91(18):1548-56. PubMed ID: 10491431
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.
    Ide T, Kitajima Y, Miyoshi A, Ohtsuka T, Mitsuno M, Ohtaka K, Koga Y, Miyazaki K.
    Int J Cancer; 2006 Dec 15; 119(12):2750-9. PubMed ID: 16998831
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K, Jin L, Fuchs A, Shi E, Chowdhury S, Yao Y, Polverini PJ, Laterra J, Goldberg ID, Rosen EM.
    Lab Invest; 1997 Mar 15; 76(3):339-53. PubMed ID: 9121117
    [Abstract] [Full Text] [Related]

  • 12. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors.
    Wilson SE, Weng J, Chwang EL, Gollahon L, Leitch AM, Shay JW.
    Cell Mol Biol Res; 1994 Mar 15; 40(4):337-50. PubMed ID: 7866434
    [Abstract] [Full Text] [Related]

  • 13. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation.
    Lal B, Xia S, Abounader R, Laterra J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4479-86. PubMed ID: 15958633
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer.
    Nagy J, Curry GW, Hillan KJ, McKay IC, Mallon E, Purushotham AD, George WD.
    Surg Oncol; 1996 Feb 15; 5(1):15-21. PubMed ID: 8837300
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H, Mansel RE, Jiang WG.
    Int J Oncol; 2005 May 15; 26(5):1429-34. PubMed ID: 15809737
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.